Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Structural characterization of cationic DODAB bilayers containing C24:1 beta-glucosylceramide

Full text
Author(s):
Martins, Leticia S. [1] ; Nomura, Daniela A. [2] ; Duarte, Evandro L. [2] ; Riske, Karin A. [1] ; Teresa Lamy, M. [2] ; Rozenfeld, Julio H. K. [1]
Total Authors: 6
Affiliation:
[1] Univ Fed Sao Paulo, Dept Biofis, Escola Paulista Med, R Botucatu 862, BR-04023062 Sao Paulo, SP - Brazil
[2] Univ Sao Paulo, Inst Fis, CP 66318, BR-05315970 Sao Paulo, SP - Brazil
Total Affiliations: 2
Document type: Journal article
Source: BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES; v. 1861, n. 3, p. 643-650, MAR 1 2019.
Web of Science Citations: 0
Abstract

The effect of 5 mol%, 9 mol%, and 16 mol% of C24:1 beta-glucosylceramide (beta GlcCer) on the structure of cationic DODAB bilayers was investigated by means of differential scanning calorimetry (DSC), electron spin resonance (ESR) spectroscopy and fluorescence microscopy. beta GlcCer is completely miscible with DODAB at all fractions tested, since no domains were observed in fluorescence microscopy or ESR spectra. The latter showed that beta GlcCer destabilized the gel phase of DODAB bilayers by decreasing the gel phase packing. As a consequence, beta GlcCer induced a decrease in the phase transition temperature and cooperativity of DODAB bilayers, as seen in DSC thermograms. ESR spectra also showed that beta GlcCer induced an increase in DODAB fluid phase order and/or rigidity. Despite their different structures, a similar effect of loosening the gel phase packing and turning the fluid phase more rigid/organized has also been observed when low molar fractions of cholesterol were incorporated in DODAB bilayers. The structural characterization of mixed membranes made of cationic lipids and glucosylceramides may be important for developing novel immunotherapeutic tools such as vaccine adjuvants. (AU)

FAPESP's process: 16/13368-4 - Nanostructured systems: from membrane biomimetic models to carriers of bioactives
Grantee:Karin Do Amaral Riske
Support Opportunities: Research Projects - Thematic Grants
FAPESP's process: 14/50983-3 - INCT 2014: complex fluids
Grantee:Antonio Martins Figueiredo Neto
Support Opportunities: Research Projects - Thematic Grants
FAPESP's process: 16/19077-1 - Development of novel vaccine adjuvants capable of activating CD1d-restricted T cells
Grantee:Julio Henrique Kravcuks Rozenfeld
Support Opportunities: Regular Research Grants